Pain News and Research

Latest Pain News and Research

State roundup: The effects of proposed Calif. budget cuts; Fewer free vaccinations in Texas

Low-income children in rural California communities are in jeopardy of losing their doctors and health care plans under Gov. Jerry Brown's budget proposal, state lawmakers, doctors and health advocates say. The governor is proposing to transfer nearly 900,000 children enrolled in Healthy Families, the state's Children's Health Insurance Program, to Medi-Cal – a program aimed at serving the state's poorest families, seniors and disabled residents.

30 May 2012

Endo, Watson reach agreement to resolve two LIDODERM patent infringement lawsuits

Endo announced today that it has reached an agreement with Watson Pharmaceuticals (Watson) resolving two patent infringement lawsuits related to LIDODERM.

30 May 2012

Cabazitaxel offers added benefit for men with metastatic prostate cancer

Cabazitaxel has been approved since March 2011 in men with metastatic prostate cancer who no longer respond to conventional therapy with hormone blockers and have already been pre-treated with the cytostatic drug docetaxel.

30 May 2012

Safety of breast implants

Following the recent scandal, described in May 2012 by the BBC as the “PIP breast implant scandal”, (1) many women may have been put off having breast implants. But how safe exactly is breast enlargement? And how do the different methods compare?

29 May 2012

Pre-harvest vaccines for management of E. coli in Canadian beef receive favourable conclusion

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a Public Health Agency of Canada study assessing the effects of various interventions on the management of E. coli O157:H7 in Canadian beef came to a favourable conclusion with regard to pre-harvest vaccines such as the Company's Econiche cattle vaccine.

29 May 2012

Spectrum initiates enrollment in RenaZorb Phase 1 trial in healthy volunteers

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, today announced the initiation of patient enrollment in a Phase 1 clinical trial evaluating the safety and tolerability of RenaZorb in healthy volunteers.

29 May 2012

Abbott to highlight latest investigational research findings on HUMIRA at EULAR 2012

Abbott scientists and independent researchers will highlight the latest investigational research findings on HUMIRA (adalimumab) at the European League Against Rheumatism (EULAR) Congress in Berlin, Germany, from 6-9 June, 2012.

29 May 2012

EMA CHMP issues positive opinion to Eisai’s Fycompa for treatment of partial-onset seizures

Eisai announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa (perampanel) as an adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older.

29 May 2012

New technique more sensitive in detecting bone loss than X-ray method

Are your bones getting stronger or weaker? Right now, it's hard to know. Scientists at Arizona State University and NASA are taking on this medical challenge by developing and applying a technique that originated in the Earth sciences. In a new study, this technique was more sensitive in detecting bone loss than the X-ray method used today, with less risk to patients. Eventually, it may find use in clinical settings, and could pave the way for additional innovative biosignatures to detect disease.

29 May 2012

Positive results from Acacia Phase II APD421 study in prevention of post-operative nausea & vomiting

Acacia Pharma announces positive results from its Phase II study of APD421, in the prevention of post-operative nausea & vomiting (PONV).

28 May 2012

Results from Medtronic’s Resolute DES clinical study on CAD

According to study results to be featured in Sunday's late-breaking clinical trials session at the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress in Philadelphia, the Resolute drug-eluting stent (DES) from Medtronic, Inc. yields strong performance in coronary artery disease (CAD) patients both with and without diabetes through two years of follow-up.

From Medtronic 28 May 2012

Bone age necessary to correctly interpret growth status in pediatric Crohn's disease

Measuring bone age should be a standard practice of care for pediatric patients with Crohn's disease, in order to properly interpret growth status and improve treatment, according to a new study from the UCSF Benioff Children's Hospital.

25 May 2012

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinoma

Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.

25 May 2012

European CHMP issues positive opinion to Vertex's KALYDECO for treatment of CF

Vertex Pharmaceuticals Incorporated announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion by consensus recommending the approval of KALYDECO (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

25 May 2012

Measuring bone age should be part of routine care for pediatric patients with Crohn's disease

25 May 2012

$IOF report predicts dramatic rise in osteoporosis-related fractures in Brazil$

IOF report predicts dramatic rise in osteoporosis-related fractures in Brazil

A new Audit report on fragility fractures, issued today by the International Osteoporosis Foundation (IOF), predicts that Brazil will experience an explosion in the number of fragility fractures due to osteoporosis in the coming decades.

25 May 2012

NIH Consortium selects UBM among 11 CoEPEs

With more Americans than ever living with chronic pain, the National Institutes of Health (NIH) Pain Consortium wants the University of Maryland, Baltimore (UMB) and 10 other health professional schools to teach the next generation of health care providers to be better equipped to manage and treat such patients.

25 May 2012

State lawmakers wrestle with Planned Parenthood funding, contraception coverage

Legislation in Pennsylvania would bar the use of state and federal funding by Planned Parenthood. Also, some Georgia physicians fear their opposition to a state abortion bill has triggered retaliation.

25 May 2012

UCSF scientists aim to use embryonic stem cells for treatment of neuropathic pain

Chronic pain, by definition, is difficult to manage, but a new study by UCSF scientists shows how a cell therapy might one day be used not only to quell some common types of persistent and difficult-to-treat pain, but also to cure the conditions that give rise to them.

25 May 2012

FDA advisory committee votes in favor of Pfizer's tafamidis meglumine

Pfizer Inc. announced today that the United States Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee voted on Pfizer's clinical data package for tafamidis meglumine.

25 May 2012

Pain News and Research

Latest Pain News and Research

State roundup: The effects of proposed Calif. budget cuts; Fewer free vaccinations in Texas

Endo, Watson reach agreement to resolve two LIDODERM patent infringement lawsuits

Cabazitaxel offers added benefit for men with metastatic prostate cancer

Safety of breast implants

Pre-harvest vaccines for management of E. coli in Canadian beef receive favourable conclusion

Spectrum initiates enrollment in RenaZorb Phase 1 trial in healthy volunteers

Abbott to highlight latest investigational research findings on HUMIRA at EULAR 2012

EMA CHMP issues positive opinion to Eisai’s Fycompa for treatment of partial-onset seizures

New technique more sensitive in detecting bone loss than X-ray method

Positive results from Acacia Phase II APD421 study in prevention of post-operative nausea & vomiting

Results from Medtronic’s Resolute DES clinical study on CAD

Bone age necessary to correctly interpret growth status in pediatric Crohn's disease

EMA CHMP adopts positive opinion for Pfizer’s axitinib to treat advanced renal cell carcinoma

European CHMP issues positive opinion to Vertex's KALYDECO for treatment of CF

Measuring bone age should be part of routine care for pediatric patients with Crohn's disease

IOF report predicts dramatic rise in osteoporosis-related fractures in Brazil

NIH Consortium selects UBM among 11 CoEPEs

State lawmakers wrestle with Planned Parenthood funding, contraception coverage

UCSF scientists aim to use embryonic stem cells for treatment of neuropathic pain

FDA advisory committee votes in favor of Pfizer's tafamidis meglumine

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Pain News and Research

Latest Pain News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in